UNSPSC 51451610: Lobendazole

This classification denotes an antihelminthic agent with the molecular formula C10H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CMF6Z78SWL, chemically known as 2-benzimidazolecarbamic acid, ethyl ester (8ci) but generally known as lobendazole, which bears US NIH Compound Identifier 22752. European Medicines Agency schedules Lobendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08542MIG.

UNSPSC 51451610 Lobendazole, a Commodity code, does not reflect the work actually being solicited under it in recent state and local opportunities. The most recent records tagged to this code show procurement of antibiotic pharmaceuticals (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and opioid-reversal medications (Naloxone), neither of which are lobendazole or anthelmintic products. State and local governments soliciting under this code appear to be using it as a catch-all or miscategorized tag for pharmaceutical inventory procurement rather than for the specific antiparasitic drug the code nominates.

The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392, $2,999,999.11 over three years with renewal options), and Seminole County, Florida released an IFB on June 30, 2026 (IFB60459723LAS, response deadline July 26, 2026) for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries. Both transactions demonstrate state-level health departments and county public-health entities sourcing pharmaceutical and medical supplies through competitive bidding and cooperative purchasing vehicles, but neither involves lobendazole. Code classification misalignment of this severity suggests that opportunities nominally tagged to 51451610 warrant close source review before resource allocation; the code does not reliably signal work in the anthelmintic pharmaceutical space.